Cronos Group Inc. - Common Share (CRON) Social Stream
CRONOS GROUP INC (CRON) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering CRONOS GROUP INC.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-11-17 | 8 | $12.5 | $5.54 | $8.255 | $2.08 | 296.88% |
2021-11-29 | 9 | $12.5 | $5 | $7.782 | $2.08 | 274.13% |
2022-01-27 | 9 | $12.5 | $3.24 | $7.526 | $2.08 | 261.83% |
2022-02-21 | 9 | $9 | $3.24 | $5.467 | $2.08 | 162.84% |
2022-02-23 | 9 | $8 | $3.24 | $4.905 | $2.08 | 135.82% |
2022-02-24 | 8 | $8 | $3.24 | $4.905 | $2.08 | 135.82% |
2022-03-02 | 8 | $5.5 | $3.24 | $4.462 | $2.08 | 114.52% |
2022-03-03 | 7 | $5.5 | $3.24 | $4.248 | $2.08 | 104.23% |
2022-03-06 | 7 | $5.5 | $3 | $4.105 | $2.08 | 97.36% |
2022-03-21 | 7 | $5.5 | $2.9 | $4.057 | $2.08 | 95.05% |
2022-05-01 | 6 | $5.5 | $2.9 | $4.233 | $2.08 | 103.51% |
2022-05-09 | 6 | $6 | $2.9 | $4.4 | $2.08 | 111.54% |
2022-05-10 | 8 | $6 | $2.9 | $4.4 | $2.08 | 111.54% |
2022-05-12 | 8 | $6 | $3 | $4.252 | $2.08 | 104.42% |
2022-05-17 | 9 | $6 | $3 | $4.254 | $2.08 | 104.52% |
2022-07-26 | 9 | $6 | $3 | $4.225 | $2.08 | 103.12% |
2022-07-29 | 9 | $7 | $3 | $4.43 | $2.08 | 112.98% |
2022-08-10 | 9 | $7 | $3 | $4.344 | $2.08 | 108.85% |
2022-09-17 | 9 | $7 | $3 | $4.307 | $2.08 | 107.07% |
2022-10-24 | 9 | $7 | $3 | $4.021 | $2.08 | 93.32% |
2022-10-25 | 9 | $7 | $2.7 | $3.978 | $2.08 | 91.25% |
2022-11-07 | 10 | $7 | $2.7 | $3.856 | $2.08 | 85.38% |
2022-11-09 | 13 | $7 | $2.5 | $3.68 | $2.08 | 76.92% |
2022-12-16 | 13 | $7 | $2.5 | $3.837 | $2.08 | 84.47% |
2023-01-09 | 13 | $7 | $2.5 | $3.71 | $2.08 | 78.37% |
2023-01-26 | 13 | $7 | $2.7 | $3.706 | $2.08 | 78.17% |
2023-01-27 | 13 | $7 | $2.5 | $3.688 | $2.08 | 77.31% |
2023-02-28 | 13 | $7 | $2.3 | $3.67 | $2.08 | 76.44% |
2023-03-02 | 13 | $5.25 | $2.1 | $3.204 | $2.08 | 54.04% |
2023-05-09 | 11 | $3.75 | $2.3 | $3.062 | $2.08 | 47.21% |
2023-05-10 | 11 | $3.75 | $1.8 | $2.999 | $2.08 | 44.18% |
2023-05-15 | 11 | $3.5 | $1.8 | $2.899 | $2.08 | 39.38% |
2023-05-18 | 12 | $3.72 | $1.8 | $2.853 | $2.08 | 37.16% |
2023-06-06 | 12 | $3.72 | $1.5 | $2.828 | $2.08 | 35.96% |
2023-06-22 | 12 | $3.72 | $1.5 | $2.8 | $2.08 | 34.62% |
2023-08-08 | 11 | $3.72 | $1.5 | $2.782 | $2.08 | 33.75% |
2023-08-10 | 11 | $3.72 | $1.5 | $2.769 | $2.08 | 33.12% |
2023-08-16 | 11 | $3.72 | $1.5 | $2.768 | $2.08 | 33.08% |
2023-09-01 | 11 | $3.69 | $1.5 | $2.761 | $2.08 | 32.74% |
2023-09-18 | 10 | $3.69 | $1.5 | $2.576 | $2.08 | 23.85% |
2023-10-31 | 9 | $3.69 | $1.5 | $2.576 | $2.08 | 23.85% |
2023-11-09 | 9 | $3.69 | $1.7 | $2.551 | $2.08 | 22.64% |
2023-11-10 | 9 | $3.69 | $1.5 | $2.529 | $2.08 | 21.59% |
2023-11-21 | 9 | $3.69 | $1.5 | $2.535 | $2.08 | 21.88% |
2023-12-27 | 9 | $3.69 | $1.986 | $2.59 | $2.08 | 24.52% |
The Trend in the Analyst Price Target
Over the past 33 months, CRON's average price target has gone down $4.3.
Over the past 48 weeks, CRON's average upside potential has been 44.09%.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2023-03-02 | 11 | 3.75 | 2.100 | 3.042 | 2.08 | 46.25% |
2023-09-18 | 10 | 3.69 | 1.500 | 2.576 | 2.25 | 14.49% |
2023-09-18 | 9 | 3.69 | 1.800 | 2.562 | 2.25 | 13.87% |
2023-10-30 | 9 | 3.69 | 1.500 | 2.576 | 1.77 | 45.54% |
2023-12-27 | 9 | 3.69 | 1.986 | 2.590 | 2.03 | 27.59% |
CRON Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
2.44 | 3 | 0 | 5 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
Over the past 31 weeks, CRON's average broker recommendation rating improved by 0.2.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, CRONOS GROUP INC's average analyst price target is higher than 144.94% of them.
- CRON has a lower variance in analysts' estimates than -4478.63% of all US stocks.
- In the context of stocks in the mid market cap category, CRONOS GROUP INC's number of analysts covering the stock is higher than 3897.94% of them.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, CRONOS GROUP INC's upside potential (average analyst target price relative to current price) is greater than 3888.89% of them.
In the Pharmaceutical Products industry, SDGR, IMAB, and BBIO are the three stocks most similar to CRONOS GROUP INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding CRON using the data that counts. Try POWR Ratings for free.